Guidelines

ACG: CRC screening should start at age 45


 

Quality indicators

For endoscopists who perform colonoscopy, the ACG recommended that all operators determine their individual cecal intubation rates, adenoma detection rates, and withdrawal times. They also recommended that endoscopists spend at least 6 minutes inspecting the mucosa during withdrawal and achieve a cecal intubation rate of at least 95% for all patients screened.

The ACG recommended remedial training for any provider whose adenoma detection rate is less than 25%.

Screening rates dropped during pandemic

The authors of the new recommendations also pointed out that, despite public health initiatives to boost CRC screening in the United States and the availability of multiple screening modalities, almost one-third of individuals who are eligible for CRC screening do not undergo screening.

Moreover, the proportion of individuals not being screened has reportedly increased during the pandemic. In one report, claims data for colonoscopies dropped by 90% during April. “Colorectal cancer screening rates must be optimized to reach the aspirational target of >80%,” the authors emphasized.

“A recommendation to be screened by a PCP [primary care provider] – who is known and trusted by the person – is clearly effective in raising participation,” they added.

Dr. Shaukat has served as a scientific consultant for Iterative Scopes and Freenome. Other ACG guideline authors reported numerous financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Hemochromatosis variants may confer 10-fold higher risk of liver cancer
Journal of Clinical Outcomes Management
Cancer rates on the rise in adolescents and young adults
Journal of Clinical Outcomes Management
Study reveals how aspirin may inhibit colorectal cancer
Journal of Clinical Outcomes Management
U.S. cancer death rates drop for second year in a row
Journal of Clinical Outcomes Management
High cost of pancreatic enzymes a barrier for patients with cancer
Journal of Clinical Outcomes Management
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Journal of Clinical Outcomes Management
EHR data harnessed to spot new risk factors for early-onset CRC
Journal of Clinical Outcomes Management
Drive By Flu-FIT: CRC screening in the COVID-19 era
Journal of Clinical Outcomes Management
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)
Journal of Clinical Outcomes Management
Missed visits during pandemic cause ‘detrimental ripple effects’
Journal of Clinical Outcomes Management